Racial and ethnic differences in reported haemophilia death rates in the United States
- PMID: 37718571
- PMCID: PMC10773975
- DOI: 10.1111/hae.14859
Racial and ethnic differences in reported haemophilia death rates in the United States
Abstract
Introduction: People with haemophilia's life expectancies have improved over time. Whether progress has been experienced equitably is unknown.
Aim: To examine recorded haemophilia death (rHD) rates according to race and ethnicity in the United States (US).
Methods: In this cohort study, rHDs were examined with US National Vital Statistics' 1999-2020 Multiple Cause-of-Death data. rHD was defined as having a haemophilia A (D66) or B (D67) ICD-10 code in the death certificate (underlying or multiple causes of death). Age-adjusted rHD rates were compared with age-adjusted rate ratios (aRR) and 95% Confidence Intervals (CI).
Results: There were 3115 rHDs in males with an rHD rate of 0.98 per 1 million males. Between 1999 and 2020, rHD rates declined by 46% in NH (Non-Hispanic) White, 44% in NH Black (aRR = 0.56, 95%CI 0.43, 0.74), and 42% in Hispanic (aRR = 0.58, 95%CI 0.39, 0.88) males. However, rHD rates remained higher and were on average 30% greater in NH Black versus NH White males (aRR = 1.30 95% CI 1.16, 1.46). Among males with rHD, the median age at death rose from 54.5 to 65.5 years between 1999 and 2020 and was 12 years lower in NH Black (56 years) versus NH White (68 years) males in 2010-2020. There were 930 females with rHD, with an age-adjusted rate of 0.22 per 1 million females, which was consistent between 1999 and 2020.
Conclusion: Reported haemophilia-death rates improved in males across all race/ethnicities, but rates were higher Black versus White males. Given the inherent limitations of the current study's data source, further investigation of survival rates and disparities in haemophilia are needed.
Keywords: death; disparities; ethnicity; haemophilia; outcomes; race.
© 2023 John Wiley & Sons Ltd.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
Christine L. Kempton: Has received honoraria for participation in advisory boards from Biomarin, Pfizer, Genentech, and Spark.
Figures
Similar articles
-
Race and ethnicity and the success of immune tolerance induction among people with severe haemophilia A in the United States.Haemophilia. 2024 May;30(3):628-637. doi: 10.1111/hae.14980. Epub 2024 Mar 10. Haemophilia. 2024. PMID: 38462837
-
State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.JAMA Oncol. 2023 May 1;9(5):700-704. doi: 10.1001/jamaoncol.2022.7835. JAMA Oncol. 2023. PMID: 36862439 Free PMC article.
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 48 States, the District of Columbia, and Puerto Rico, 2021.MMWR Surveill Summ. 2024 Jul 11;73(5):1-44. doi: 10.15585/mmwr.ss7305a1. MMWR Surveill Summ. 2024. PMID: 38980822 Free PMC article.
-
Disparities in wellbeing in the USA by race and ethnicity, age, sex, and location, 2008-21: an analysis using the Human Development Index.Lancet. 2024 Dec 7;404(10469):2261-2277. doi: 10.1016/S0140-6736(24)01757-4. Epub 2024 Nov 7. Lancet. 2024. PMID: 39522526
-
Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.PLoS Med. 2020 Oct 20;17(10):e1003402. doi: 10.1371/journal.pmed.1003402. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33079941 Free PMC article.
Cited by
-
From Vision to Action: National Bleeding Disorders Foundation's Roadmap for Achieving Health Equity, Diversity, and Inclusion.Health Equity. 2025 Mar 11;9(1):144-160. doi: 10.1089/heq.2024.0146. eCollection 2025. Health Equity. 2025. PMID: 40677640 Free PMC article. Review.
-
Emerging Therapies in Hemophilia: Improving Equitable Access to Care.J Blood Med. 2025 Feb 20;16:95-115. doi: 10.2147/JBM.S490588. eCollection 2025. J Blood Med. 2025. PMID: 39995897 Free PMC article. Review.
References
-
- Chorba TL, Holman RC, Clarke MJ, Evatt BL. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. Am J Hematol. 2001;66(4):229–240. - PubMed
-
- Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41(2):194–200. - PubMed
-
- Payne AB, Ghaji N, Mehal JM, et al. Mortality Trends and Causes of Death in Persons with Hemophilia in the United States, 1999–2014. Blood. 2017(8):1.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical